Patisiran, an RNAi Therapeutic, for Hereditary Transthyretin Amyloidosis
Abstract
Patisiran, an investigational RNA interference therapeutic agent, specifically inhibits hepatic synthesis of...
Paper Details
Title
Patisiran, an RNAi Therapeutic, for Hereditary Transthyretin Amyloidosis
Published Date
Jul 5, 2018
Volume
379
Issue
1
Pages
11 - 21
Citation AnalysisPro
You’ll need to upgrade your plan to Pro
Looking to understand the true influence of a researcher’s work across journals & affiliations?
- Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
- Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.
Notes
History